KTTA

Pasithea Therapeutics Corp. (KTTA) Porter's 5 Forces Analysis (2026)

Invetso Score: 5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Overall Score

Score: 5.0 (Moderate)

Bargaining Power Of Suppliers

Score:

Supplier power appears moderate given the company’s very large cash balance and current ratio of 26.25x, which reduces near-term dependence on external financing.

However, the business still shows weak operating performance and negative margins, limiting evidence of durable supplier leverage advantages.

Bargaining Power Of Buyers

Score:

Buyer power remains moderate because the company is not demonstrating pricing power, with TTM gross, operating, and net margins all at 0% or below.

The extremely low price-to-sales ratio and distressed profitability profile suggest customers likely have meaningful negotiating leverage.

Threat Of Substitutes

Score:

Substitution risk remains moderate as the company has not shown differentiated economics that would clearly insulate it from alternatives.

Persistent losses and zero revenue metrics indicate limited evidence of a strong moat against substitute offerings.

Threat Of New Entrants

Score:

Barriers to entry appear moderate because the company’s balance sheet is liquid, but the business itself does not show scale or profitability advantages that would deter entrants.

The lack of positive returns on capital suggests any competitive edge is weak and not yet self-reinforcing.

Rivalry Among Existing Competitors

Score:

Competitive rivalry appears moderate to high because the company is operating with zero margins and negative returns, implying a difficult industry backdrop or weak positioning.

There is no evidence of strong differentiation or sustained profitability that would reduce competitive intensity.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Pasithea Therapeutics Corp.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →